Mechanistically, the oncogenic capabilities of RUNX2 were attributed to its downregulation of the tumor suppressor NOLC1, which subsequently facilitated the growth and metastasis of ccRCC cells [73]. Here, RUNX2 is linked to nonpapillary renal cell carcinoma.